Systemic Management of Advanced Hepatocellular Carcinoma Patients: The Role of Multi-Targeted Anti-Angiogenic Inhibitors

doi 10.5772/27152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2018English

New Systemic Treatments in Advanced Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2019English

Prognostic Role of Circulating Angiogenic Markers in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation and Liver Resection

HPB
HepatologyGastroenterology
2016English

Molecular Targeted Therapy of Hepatocellular Carcinoma

Journal of Cancer Therapy
2013English

High Immunosuppressive Burden in Advanced Hepatocellular Carcinoma Patients

OncoImmunology
OncologyAllergyImmunology
2013English

Medical Oncology Management of Advanced Hepatocellular Carcinoma 2019: A Reality Check

Frontiers of Medicine
Medicine
2019English

The Evolving Role of Transarterial Chemoembolization in the Management of Hepatocellular Carcinoma

Hepatoma Research
2015English

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Cerebrovascular Ischemic Events in Patients With Advanced Renal Cell Carcinoma Treated With Anti-Angiogenic Tyrosine Kinase Inhibitors: A Report on Two Cases With Different Outcomes

Journal of Medical Cases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy